Financials
- Market Capitalization 38.29 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 医薬品メーカー(特殊・ジェネリック)
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.17
売上高対価格比率
-7.22
1株当たり配当金
49.5
配当利回り(%)
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4263 | INCR Intercure Ltd. - ordinary shares | 0.98 USD | -2.00% | +2.08% | +4.26% | -35.53% | 53.59 M USD | ||
| 4309 | SCYX SCYNEXIS, Inc. - Common Stock | 4.75 USD | -3.65% | +3.71% | +15.85% | +533.33% | 47.17 M USD | ||
| 4427 | ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 0.75 USD | +2.74% | -2.60% | -6.25% | -69.26% | 35.54 M USD | ||
| 4527 | CPHI China Pharma Holdings, Inc. Common Stock | 0.64 USD | +4.92% | 0.00% | -15.79% | -3.19% | 25.93 M USD |